Determination of the coenzyme Q10 status in a large Caucasian study population

BioFactors

Volumn 41, Issue 4, 2015, Pages 211-221

  Onur, Simone ^a   Niklowitz, Petra ^b   Fischer, Alexandra ^a   Jacobs, Gunnar ^a   Lieb, Wolfgang ^a   Laudes, Matthias ^c   Menke, Thomas ^b   Döring, Frank ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Coenzyme Q10; Coenzyme Q10 redox state; Cohort study; Ubiquinol

Indexed keywords

BIOLOGICAL MARKER; UBIDECARENONE; UBIQUINOL-10; UBIQUINONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEALTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; METABOLIC SYNDROME X; NEUROPATHY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; DEGENERATIVE DISEASE; HEART FAILURE; HEART INFARCTION; INFLAMMATION; LIPID METABOLISM; MIDDLE AGED; NEOPLASM; PAIN; PERIPHERAL NEUROPATHY; QUESTIONNAIRE; VERY ELDERLY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; NEURODEGENERATIVE DISEASES; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; SURVEYS AND QUESTIONNAIRES; UBIQUINONE;

EID: 84939549353     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1216     Document Type: Article

References (40)

1. Crane, F.L. (2001) Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20, 591-598.
2. Traut, T.W., Payne, R.C., and Jones, M.E. (1980) Dependence of the aggregation and conformation states of uridine 5'-phosphate synthase on pyrimidine nucleotides. Evidence for a regulatory site. Biochemistry 19, 6062-6068.
3. King, M.S., Sharpley, M.S., and Hirst, J. (2009) Reduction of hydrophilic ubiquinones by the flavin in mitochondrial NADH:ubiquinone oxidoreductase (Complex I) and production of reactive oxygen species. Biochemistry 48, 2053-2062.
4. Navas, P., Fernandez-Ayala, D.M., Martin, S.F., Lopez-Lluch, G., De Caboa, R., et al. (2002) Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells. Free Radic. Res. 36, 369-374.
5. Schmelzer, C., Kitano, M., Rimbach, G., Niklowitz, P., Menke, T., et al. (2009) Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo. Mediators Inflamm. 2009, 415437.
6. Schmelzer, C., Kubo, H., Mori, M., Sawashita, J., Kitano, M., et al. (2010) Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice. Mol. Nutr. Food Res. 54, 805-815.
7. Schmelzer, C., Okun, J.G., Haas, D., Higuchi, K., Sawashita, J., et al. (2010) The reduced form of coenzyme Q10 mediates distinct effects on cholesterol metabolism at the transcriptional and metabolite level in SAMP1 mice. IUBMB Life 62, 812-818.
8. Schmelzer, C., Niklowitz, P., Okun, J.G., Haas, D., Menke, T., et al. (2011) Ubiquinol-induced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans. IUBMB Life 63, 42-48.
9. Schmelzer, C. and Doring, F. (2010) Identification of LPS-inducible genes downregulated by ubiquinone in human THP-1 monocytes. Biofactors 36, 222-228.
10. Bakalova, R., Goudev, A., Zhelev, Z., and Nachev, C. (1995) Oxidative modifications of blood serum in humans with coronary artery disease. Acta Physiol. Pharmacol. Bulg. 21, 81-85.
11. Hofman-Bang, C., Rehnqvist, N., Swedberg, K., Wiklund, I., and Astrom, H. (1995), Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. J. Card. Fail. 1, 101-107.
12. Kumar, A., Singh, R.B., Saxena, M., Niaz, M.A., Josh, S.R., et al. (2007), Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study. Acta Cardiol 62, 349-354.
13. Langsjoen, P.H. and Langsjoen, A.M. (2008) Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors 32, 119-128.
14. Cleary, J., Mohr, D., Adams, M.R., Celermajer, D.S., and Stocker, R. (1997) Plasma and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and age-matched controls. Free Radic. Res. 26, 175-182.
15. Kontush, A., Spranger, T., Reich, A., Baum, K., and Beisiegel, U. (1999) Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis 144, 117-122.
16. Lagendijk, J., Ubbink, J.B., Delport, R., Vermaak, W.J., and Human, J.A. (1997) Ubiquinol/ubiquinone ratio as marker of oxidative stress in coronary artery disease. Res. Commun. Mol. Pathol Pharmacol 95, 11-20.
17. Miles, M.V., Morrison, J.A., Horn, P.S., Tang, P.H., and Pesce, A.J. (2004) Coenzyme Q10 changes are associated with metabolic syndrome. Clin. Chim. Acta 344, 173-179.
18. Mortensen, S.A., Kumar, A., Dolliner, P., Filipiak, K.J., Pella, D., et al. (2013) The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure. Results from the Q-SYMBIO study. European Journal of Heart Failure. 12, S21.
19. Lu, J. and Frank, E.L. (2007) Measurement of coenzyme Q10 in clinical practice. Clin. Chim. Acta 384, 180-181.
20. Krawczak, M., Nikolaus, S., von Eberstein, H., Croucher, P.J., El Mokhtari, N.E., et al. (2006) PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 9, 55-61.
21. Nothlings, U. and Krawczak, M. (2012) [PopGen. A population-based biobank with prospective follow-up of a control group]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55, 831-835.
22. Müller, N., Türk, K., Freitag-Wolf, S., Hampe, J., Zeuner, et al. (2015) Interleukin-6 blockade by monoclonal antibodies as potential therapeutic option to treat elevated lipoprotein(a) serum levels in human subjects. J. Lipid Res. 56, 1034-1042.
23. Menke, T., Niklowitz, P., Adam, S., Weber, M., Schluter, B., et al. (2000) Simultaneous detection of ubiquinol-10, ubiquinone-10, and tocopherols in human plasma microsamples and macrosamples as a marker of oxidative damage in neonates and infants. Anal. Biochem. 282, 209.
24. Miles, M.V., et al. (2004) Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin. Chim. Acta 347, 139-144.
25. Onur, S, et al. (2014) A comparative study into alterations of coenzyme Q redox status in ageing pigs, mice, and worms. Biofactors 40, 346-354.
26. Folkers, K., Vadhanavikit, S., and Mortensen, S.A. (1985) Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc. Natl. Acad. Sci. USA 82, 901-904.
27. Molyneux, S.L, et al. (2008) Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J. Am. Coll. Cardiol. 52, 1435-1441.
28. Onur, S., et al. (2014), Ubiquinol reduces gamma glutamyltransferase as a marker of oxidative stress in humans. BMC Res. Notes 7, 427.
29. Onur, S., et al. (2015), Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects. Biofactors 41, 35-43.
30. Miles, M.V., et al. (2003) Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin. Chim. Acta 332, 123-132.
31. Callaghan, B.C., et al. (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 11, 521-534.
32. Zhang, Y.P., et al. (2013) Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10. Neurobiol. Dis. 58, 169-178.
33. Zhang, Y.P., et al. (2013) Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. Anesthesiology 118, 945-954.
34. Shi, T.J., et al. (2013), Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proc. Natl. Acad. Sci. USA 110, 690-695.
35. Langsjoen, P.H., et al. (2005) Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Biofactors 25, 147-152.
36. Hernandez-Ojeda, J., et al. (2012) The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study. J. Diabetes Complications 26, 352-358.
37. Miyake, Y, et al. (1999) Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneimittelforschung 49, 324-329.
38. El-ghoroury, E.A., et al. (2009) Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control. Blood Coagul. Fibrinolysis 20, 248-251.
39. Theuri, G, et al. (2013) Effects of lifestyle on plasma levels of the IGF system and the antioxidants coenzyme Q10 and vitamin E in Kenyan rural and urban populations. Growth Horm. IGF Res. 23, 68-75.
40. Tekle, M., et al. (2010) Plasma levels of insulin-like growth factor-I, insulin-like growth factor binding protein-1, coenzyme Q10 and vitamin E in female populations from Poland, Serbia and Sweden. Environ. Int. 36, 188-194.